|
Profile
|
Delegates :
Hiroaki Adachi |

|
Incorporated :
July 1 , 2005 |
Paid in Capital :
60 Million yen |
Employees :
6 人 |
Address :
313 Photonics Center bldg., Osaka University 2-1 Yamadaoka, Suita OSAKA
〒565-0871
|
TEL/FAX :
+81-6-6877-5659 / +81-6-6877-5659 |
URL:
http://www.so-sho.jp/ |
Attachment :
|
Mission/Background :
Our company was established in July 2005 as a business venture originating from Osaka University. We have a history of about 12 years in our mainline business of consignment production of crystals from difficult-to-crystallize proteins and pharmaceutical candidate compounds (organic small molecules). Unique ideas based on cross-field collaboration under the free research environment of the university produced such innovative crystal growth technologies as crystal nucleation by laser irradiation and solution agitation. |
Technology & Business
|
(1) Consignment crystallization of pharmaceutical candidate compounds (organic small molecules) and proteins, and consignment X-ray crystal structure analysis. (2) Production service for genetically modified proteins and one-stop service for drug development support. (3) Development, manufacturing, and sales of crystallization tools (product names: GAIN Plate, Crystal Catcher, Crystal Remover, Micro Knife, Micro Catcher, etc.).
|
Products & Service
|
Products & Service Name
|
Stage
|
Outline
|
Milestone
|
Crystallization service
|
Service/Marketing
|
Production of crystals from difficult-to-crystallize proteins and pharmaceutical candidate compounds
|
Expand services
|
X-ray crystal structure analysis
|
Service/Marketing
|
X-ray crystal structure analysis of proteins and organic small molecules
|
Expand services
|
|
|
|
|
|
|
|
|
|
|
|
|
Highlights
|
Our technology involves using a unique technique of aggressively controlling crystal growth. This has improved the probability of success from about 20% by conventional methods to about 70%. The extensive experience, knowledge, and know-how we have accumulated so far have led to a consignment crystallization service with high added value.
|
Alliance strategy
|
Development of protein crystal growth technology; research on crystallization of proteins and organic small molecules, and X-ray crystal structure analysis; and research concerning development of new protein crystallization technology. R&D concerning the crystallization of organic small molecules and crystal polymorphism.
|
|
|